Higher t-PA activity in HF patients is paralleled by smaller amounts of t-PA–PAI-1 complex, higher levels of plasmin–antiplasmin, and, finally, fibrin degradation metabolites (d-dimer). The gene discussed is PLG; the disease is hydrops fetalis.